MARKER THERAPEUTICS, INC. Increase (Decrease) in Finance Receivables
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Finance Receivables of -$15.43 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInFinanceReceivables · last filed 2014-11-19
- MARKER THERAPEUTICS, INC. increase (decrease) in finance receivables for the quarter ending 2014-09-30 was -$15.43K.
- MARKER THERAPEUTICS, INC. increase (decrease) in finance receivables for the quarter ending 2013-09-30 was -$22.96K.
| Period end | Increase (Decrease) in Finance Receivables 3 month | Increase (Decrease) in Finance Receivables 9 month |
|---|---|---|
| 2014-09-30 | -$15.43K 10-Q · filed 2014-11-19 | -$83.25K 10-Q · filed 2014-11-19 |
| 2013-09-30 | -$22.96K 10-Q · filed 2014-11-19 | -$139.84K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |